Completely relieved for up to 8 years! China’s innovative CAR-T therapy brings the dawn of “cure” for advanced cancer

Two long-term disease-free survival cases of advanced liver cancer treated with CAR-GPC3 T cell therapy developed by Chinese scientists were published in the internationally renowned immunology journal Cancer Communications. One of the patients has achieved complete remission of the tumor for 8 years, which is a major breakthrough in China’s anti-cancer research. This therapy is expected to cure solid tumors through innovative treatment strategies, bringing new hope to patients with advanced liver cancer.
No Tag have Found!

By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.

© Copyright 2023 Advanced Medicine In China. All rights reserved.